1. [A Case of Pathological Complete Response Achieved with Neoadjuvant DCS Therapy in Gastric Cancer].
- Author
-
Kuge K, Sakurazawa N, Yoshimori D, Yasuda T, Arai H, Kakinuma D, Watanabe M, Suzuki H, and Yoshida H
- Subjects
- Male, Humans, Aged, Neoadjuvant Therapy, Cisplatin, Docetaxel, Anorexia, Pathologic Complete Response, Stomach Neoplasms drug therapy, Stomach Neoplasms surgery
- Abstract
A 77-year-old man with appetite loss was referred to our hospital. Upper gastrointestinal endoscopy and computed tomography(CT)revealed advanced gastric cancer in the antrum with duodenal and pancreatic invasion. After 6 courses of neoadjuvant docetaxel, cisplatin, and S-1(DCS)therapy, CT revealed marked tumor shrinkage. Distal gastrectomy was performed. Histopathological examination showed no residual tumor cells or lymph node metastasis, and thus, finally, pathological complete response was considered to have been achieved. The patient was doing well and disease-free 3 years later. Thus, neoadjuvant DCS therapy can be a promising treatment option for borderline resectable advanced gastric cancer.
- Published
- 2023